• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, August 27, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Wiley’s new premier open research next journals now open for article submissions

Bioengineer by Bioengineer
April 23, 2019
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

HOBOKEN, N.J.–April 23, 2019–John Wiley and Sons Inc., (NYSE: JW-A) (NYSE: JW-B) is now inviting original research articles for two newly formed open access journals, Genetics & Genomics Next and Neuroscience Next. The journals are led by esteemed Editors-in-Chief who will publish the highest quality, most impactful and groundbreaking research while embracing open research practices. The premier journals will lead Wiley’s continued push for open research with tailored editorial guidance and transparent decision-making.

Wiley’s Research Chief Product Officer, Jay Flynn, comments, “the Next journals signal Wiley’s focus and commitment to researchers and open publishing. We are excited to have these journals lead our growing open access portfolio.”

“Neuroscience as a scientific discipline is continually evolving and expanding,” said Min Cho, Editor-in-Chief, Neuroscience Next. “We will seek out studies that anticipate and open new lines of research.” Neuroscience Next invites research in all disciplines of neuroscience, encompassing studies of formation, function or dysfunction of the nervous system at all levels. The journal will also seek research that fuses neuroscience to other disciplines in the life and physical sciences.

Myles Axton, Editor-in-Chief, Genetics & Genomics Next adds, “researchers in genetics and genomics have always embraced reproducible research and data because these underpin life, health and agriculture. We will give proper credit to the diverse and brilliant researchers in our open, transparent journal.” Genetics & Genomics Next will publish articles and resources of the highest interest and value, forward-looking perspectives to inspire the field, and analyses to provide credit for data reuse.

Oxford University Professor John A. Todd, who is a member of the Editorial Advisory Board of Genetics & Genomics Next notes, “data sharing and open research are key to accelerate translating genetic knowledge about the causes of common and rare diseases to the clinic and in drug development.”

The first two Next journals will explore and exemplify the ways Wiley incentivizes and optimizes the reporting of open research. They will exhibit transparency in both research content and the editorial process. As part of this process, the editors will make active and objective decisions and closely collaborate with external community reviewers and expert advisors to provide the best author services possible.

###

Additional Information

About Wiley

Wiley is a global leader in research and education. Our online scientific, technical, medical, and scholarly journals, and our digital learning, assessment, certification and student-lifecycle services and solutions help universities, academic societies, businesses, governments and individuals to achieve their academic and professional goals. For more than 200 years, we have delivered consistent performance to our stakeholders. The Company’s website can be accessed at?http://www.wiley.com.

Contact:

John Wiley and Sons Inc.

Tom Griffin (UK), +44 (0) 1865 476213

[email protected]

Media Contact
Tom Griffin
[email protected]

Tags: GeneticsMedicine/HealthneurobiologyPublic Health
Share12Tweet8Share2ShareShareShare2

Related Posts

Auricular Acupuncture Effective for Tension-Type Headaches

August 27, 2025

New 18F-labeled Compound Targets COX-2 Imaging

August 27, 2025

New Study Highlights Positive Impact of Diet and Exercise on Alcohol-Induced Liver Damage

August 27, 2025

CytoSorb® Enhanced Hemadsorption in Cardiac Surgery Outcomes

August 27, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    148 shares
    Share 59 Tweet 37
  • Molecules in Focus: Capturing the Timeless Dance of Particles

    142 shares
    Share 57 Tweet 36
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    115 shares
    Share 46 Tweet 29
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    81 shares
    Share 32 Tweet 20

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Smallholder Dairy Farmers Embrace On-Farm Food Safety

Early vs. Delayed Extubation in Brain Metastasis Surgery

Auricular Acupuncture Effective for Tension-Type Headaches

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.